Hongliang Biopharma
弘亮生物医药
Hongliang Biopharma
Biotech/Healthcare
Hongliang Biopharma is a biomedical services company focused on the R&D, application, and commercialization of RNA therapeutics and innovative drug delivery technologies. Its drug candidates target major diseases, including various cancers, genetic disorders, hypertension, and hyperlipidemia.
Latest round: Angel (2023)
Source: ChinaBulls — chinabulls.com
Last updated 2023-02-01
Funding history
Request access to view this section.
Investors
Request access to view this section.
HQ & website
Request access to view this section.
Tags
Request access to view this section.